featured
CPX-351 Treatment in Secondary Acute Myeloblastic Leukemia Is Effective and Improves the Feasibility of Allogeneic Stem Cell Transplantation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Cancer Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
CPX-351 Treatment in Secondary Acute Myeloblastic Leukemia Is Effective and Improves the Feasibility of Allogeneic Stem Cell Transplantation: Results of the Italian Compassionate Use Program
Blood Cancer J 2020 Oct 06;[EPub Ahead of Print], F Guolo, L Fianchi, P Minetto, M Clavio, M Gottardi, S Galimberti, G Rizzuto, M Rondoni, G Bertani, M Dargenio, A Bilio, B Scappini, P Zappasodi, AM Scattolin, F Grimaldi, G Pietrantuono, P Musto, M Cerrano, S D'Ardia, E Audisio, A Cignetti, C Pasciolla, F Pavesi, A Candoni, C Gurreri, M Morselli, C Alati, N Fracchiolla, G Rossi, M Caizzi, F Carnevale-Schianca, A Tafuri, G Rossi, F Ferrara, L Pagano, RM LemoliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.